Product Recalls in Delaware

Product recalls affecting Delaware — including food, drugs, consumer products, medical devices, and vehicles distributed to Delaware. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,695 recalls have been distributed to Delaware in the last 12 months.

48,330 total recalls
2,695 in last 12 months

Showing 9811000 of 13,379 recalls

DrugJuly 22, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Recalled by Glenmark Pharmaceuticals Inc., USA Due to CGMP Deviations

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2024· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective container; yellow colored spike from cap lodged in the nozzle

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2024· MAIN PRODUCTS INC

Recalled Item: Umary Acido Hialuronico Recalled by MAIN PRODUCTS INC Due to Undeclared...

The Issue: Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 12, 2024· Supercore Products Group Inc.

Recalled Item: Gold Hard Steel Plus Liquid Recalled by Supercore Products Group Inc. Due to...

The Issue: Marketed without an approved NDA/ANDA: FDA analysis found products to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 12, 2024· Supercore Products Group Inc.

Recalled Item: Hard Steel Capsules packaged in 1 count blister packs in boxes of 10...

The Issue: Marketed without an approved NDA/ANDA: FDA analysis found products to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 12, 2024· SoloVital

Recalled Item: Umary Acido Hialuronico Recalled by SoloVital Due to Undeclared Diclofenac

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 10, 2024· Endo Pharmaceuticals, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo Pharmaceuticals,...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 9, 2024· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Nitrofurantoin Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 3, 2024· TAILSTORM HEALTH INC

Recalled Item: Lidocaine HCL Injection Recalled by TAILSTORM HEALTH INC Due to Subpotent...

The Issue: Subpotent Drug: reduced efficacy for epinephrine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 2, 2024· Novel Laboratories, Inc. d.b.a Lupin Somerset

Recalled Item: PEG-3350 Recalled by Novel Laboratories, Inc. d.b.a Lupin Somerset Due to...

The Issue: Defective container: potential for non-sealed pouches which can lead to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 2, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Verapamil Hydrochloride Injection Recalled by Zydus Pharmaceuticals (USA)...

The Issue: Cross contamination with other products.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 2, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Verapamil Hydrochloride Injection Recalled by Zydus Pharmaceuticals (USA)...

The Issue: Cross contamination with other products.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 2, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Micafungin for injection Recalled by Zydus Pharmaceuticals (USA) Inc Due to...

The Issue: Cross contamination with other products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 2, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Micafungin for injection Recalled by Zydus Pharmaceuticals (USA) Inc Due to...

The Issue: Cross contamination with other products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 2, 2024· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Decitabine for Injection 50mg per vial Recalled by SUN PHARMACEUTICAL...

The Issue: CGMP Deviations: Out of Specification for Total Aerobic Microbial Count...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 28, 2024· Teva Pharmaceuticals USA, Inc

Recalled Item: Fludrocortisone Acetate Tablets Recalled by Teva Pharmaceuticals USA, Inc...

The Issue: Failed Impurities/Degradation Specifications: Product is being recalled due...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 28, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: Failed Dissolution Specifications: results below specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2024· Guru Inc.

Recalled Item: Infla-650 Herbal Dietary Supplement Recalled by Guru Inc. Due to Undeclared...

The Issue: Marketed without an approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 26, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Sevelamer Carbonate for Oral Suspension 0.8g packets Recalled by Dr. Reddy's...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 26, 2024· RemedyRepack Inc.

Recalled Item: Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules Recalled...

The Issue: CGMP Deviations: Out of specification for dissolution

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund